Wells Fargo analyst Finian O’Shea lowered the firm’s price target on Crescent Capital BDC (CCAP) to $15 from $16 and keeps an Equal Weight rating on the shares. The firm says that Falling base rates are likely a strong headwind to Crescent Capital BDC given its tighter net interest margin profile.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCAP: